AusBiotech seeks to maintain pressure on regulatory reform

Australia’s Senate has determined that an inquiry is needed to consider the latest proposed legislation to improve public access to therapeutics.

This raft of recommendations of the Medicines and Medical Devices Regulation Review (MMDR), previously planned for implementation in January 2018, was subject to the passage of amendments to the Therapeutic Goods Act and Regulations, which are now the subject of the inquiry.

The bill is aimed at realizing of regulatory reform for the approval of medicines and medical devices in Australia, and bringing long-awaited improvements to the environment for the development of new health technologies.